JIN-A04, Highly Effective and Brain-penetrant Tyrosine Kinase Inhibitor Targeting HER2 Exon20 Insertion Mutations in NSCLC

被引：0

作者：

Yu, M. R. ^{[1
]}

Yun, M. R. ^{[1
]}

Cho, H. B. ^{[2
]}

Choi, H. B. ^{[3
]}

Dong, G. ^{[3
]}

Choi, S. J. ^{[3
]}

Oh, S. Y. ^{[4
]}

Lee, E. J. ^{[4
]}

Duggirala, K. B. ^{[5
]}

Lee, K. ^{[5
]}

Lee, J. B. ^{[6
]}

Lim, S. M. M. ^{[7
]}

Hong, M. H. ^{[7
]}

Jo, A. ^{[8
]}

Seah, E. ^{[8
]}

Kim, C. ^{[8
]}

Cho, B. C. ^{[6
]}

机构：

[1] Yonsei Univ, Coll Med, Yonsei New Han Inst Integrat Lung Canc Res 2, Seoul, South Korea

[2] Univ Penn, Sch Arts & Sci, Dept Biol, Philadelphia, PA 19104 USA

[3] Yonsei Univ, Coll Med, Yonsei Biomed Res Inst, Seoul, South Korea

[4] Yonsei Univ, Coll Med, Brain Korea Project 21, Dept Med Sci,Grad Sch Med Sci, Seoul, South Korea

[5] Korea Res Inst Chem Technol, Bio & Drug Discovery Div, Daejeon, South Korea

[6] Yonsei Univ, Coll Med, Yonsei Canc Ctr, Div Med Oncol, Seoul, South Korea

[7] Yonsei Univ, Coll Med, Dept Internal Med, Div Med Oncol, Seoul, South Korea

[8] J INTS BIO Inc, Seoul, South Korea

来源：

关键词：

NSCLC; HER2; Exon20; Insertion; Tyrosine Kinase Inhibitor;

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

P2.09-11

引用

页码：S335 / S336

页数：2